Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002
- PMID: 16758417
- DOI: 10.1086/504804
Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002
Abstract
Background: Outbreaks of meningococcal disease are infrequent but important public health events. We characterize outbreak-associated cases in the United States and compare them with sporadic disease.
Methods: Outbreaks of meningococcal disease that occurred during the period of 1 July 1994 through 30 June 2002 were identified through state health departments, Centers for Disease Control and Prevention records, and a review of newspapers and the medical literature. Cases associated with outbreaks were compared with sporadic cases identified through population-based surveillance.
Results: We identified 69 outbreaks of Neisseria meningitidis infection (median, 9.5 outbreaks per year; range, 3-14 outbreaks per year), which involved 229 patients from 30 states. Forty-three (62%) of the outbreaks involved N. meningitidis serogroup C, 17 (25%) involved serogroup B, and 9 (13%) involved serogroup Y. Twenty-five outbreaks (36%) occurred in communities, and 44 (64%) were organization based, including 12 that occurred in colleges and universities, 19 that occurred in primary and secondary schools, and 8 that occurred in nursing homes. Vaccination campaigns (with the A/C/Y/W-135 meningococcal polysaccharide vaccine) were conducted for 31 outbreaks (28 involving serogroup C and 3 involving serogroup Y). After controlling for age, serogroup, and clinical presentation, outbreak-associated cases were associated with a higher case-fatality rate than were sporadic cases (21% vs. 11%; odds ratio, 3.3; 95% confidence interval, 2.0-5.5).
Conclusions: Outbreaks remain an important but infrequent public health issue, representing <2% of all cases of meningococcal disease. However, given the increased case-fatality rate found among outbreak-related cases of N. meningitidis infection, additional investigation of factors that favor the transmission and virulence of outbreak-related strains is warranted.
Similar articles
-
Recent epidemiological changes in meningococcal disease may be due to the displacement of serogroup A by serogroup C in Hefei City, China.Postgrad Med J. 2008 Feb;84(988):87-92. doi: 10.1136/pgmj.2007.065680. Postgrad Med J. 2008. PMID: 18322129
-
[Meningococcal disease in Spain, 1990-1997. Change in its epidemiological pattern].Rev Esp Salud Publica. 2000 Jul-Aug;74(4):387-96. Rev Esp Salud Publica. 2000. PMID: 11031848 Spanish.
-
Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York.Clin Infect Dis. 2009 Apr 1;48(7):894-901. doi: 10.1086/597257. Clin Infect Dis. 2009. PMID: 19231975
-
Global epidemiology of meningococcal disease.Vaccine. 2009 Jun 24;27 Suppl 2:B51-63. doi: 10.1016/j.vaccine.2009.04.063. Epub 2009 May 27. Vaccine. 2009. PMID: 19477562 Review.
-
Prevention of meningococcal disease.Am Fam Physician. 2005 Nov 15;72(10):2049-56. Am Fam Physician. 2005. PMID: 16342836 Review.
Cited by
-
Meningococcal groups C and Y and haemophilus B tetanus toxoid conjugate vaccine (HibMenCY-TT; MenHibrix(®)): a review.Drugs. 2013 May;73(7):703-13. doi: 10.1007/s40265-013-0048-9. Drugs. 2013. PMID: 23649970 Review.
-
Molecular epidemiology of Neisseria meningitidis isolates from an outbreak of meningococcal disease among men who have sex with men, Chicago, Illinois, 2003.J Clin Microbiol. 2007 Nov;45(11):3768-70. doi: 10.1128/JCM.01190-07. Epub 2007 Aug 29. J Clin Microbiol. 2007. PMID: 17728467 Free PMC article.
-
The changing epidemiology of meningococcal disease in North America 1945-2010.Hum Vaccin Immunother. 2013 Jan;9(1):162-71. doi: 10.4161/hv.22302. Epub 2012 Oct 29. Hum Vaccin Immunother. 2013. PMID: 23108355 Free PMC article. Review.
-
Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination.Hum Vaccin Immunother. 2019;15(2):459-469. doi: 10.1080/21645515.2018.1528831. Epub 2018 Oct 29. Hum Vaccin Immunother. 2019. PMID: 30273506 Free PMC article. Review.
-
US College Students Are at Increased Risk for Serogroup B Meningococcal Disease.J Pediatric Infect Dis Soc. 2020 Apr 30;9(2):244-247. doi: 10.1093/jpids/piz024. J Pediatric Infect Dis Soc. 2020. PMID: 31077326 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical